| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_71b3be70086419df7430dcf0abc1da93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18b787b9d8e05e2b111729585891281e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dd6198d25659eec5151869f6de907eed |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-33 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-258
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J17-00 |
| filingDate |
1996-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1999-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92cc502bc67645d9c503b556836a63ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ff09001da7c3335d94eedcdd289013e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7257c607442a6b10dc6d79f1d06ca0d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7907ea8a7bdc40bb7bb40d7db4a02c38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47f321247112244689bc18409a8d74b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1a1abe3d338ee5c8b9629b9e929363b |
| publicationDate |
1999-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-100201585-B1 |
| titleOfInvention |
Vasodilator composition |
| abstract |
The present invention relates to a vasodilator composition comprising ginsenoside Rg 3 and / or Rg 5 as one of the components of ginseng as an active ingredient. Ginsenosides Rg 3 and Rg 5 , the active ingredients of the composition according to the present invention exhibits vascular relaxation in an endothelial manner, and unlike general saponin components, do not destroy endothelial cells and thus can be used without side effects such as hemolytic action or fish toxicity. It is a safe medicinal ingredient. Ginsenosides Rg 3 and Rg 5 are rarely present in ginseng plants such as ginseng and white ginseng, and are present only in trace amounts in red ginseng.The contents of ginseng plants are heated by heating the ginseng plants at a high temperature of 110 to 180 ° C. for 0.5 to 20 hours This increases significantly. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100740609-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100504966-B1 |
| priorityDate |
1995-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |